Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus

被引:2
|
作者
Song, Do Kyeong [1 ]
Hong, Young Sun [1 ]
Sung, Yeon-Ah [1 ]
Lee, Hyejin [1 ]
机构
[1] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea
来源
PLOS ONE | 2024年 / 19卷 / 02期
关键词
CAUSE-SPECIFIC MORTALITY; MULTIFACTORIAL INTERVENTION; BLOOD-PRESSURE; DISEASE; OUTCOMES;
D O I
10.1371/journal.pone.0299035
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Since patients with type 2 diabetes mellitus (T2DM) have an increased risk of cardiovascular events, interventions addressing risk factors reduce the incidence of cardiovascular disease (CVD) events. This study aimed to evaluate the difference in the incidence of CVD events according to risk factor control in patients with diabetes with and without cardio-renal disease.Methods We analyzed 113,909 patients with diabetes and 290,339 without diabetes using data released by the National Health Insurance Service (NHIS).Results Among patients with diabetes with four or five poorly controlled risk factors, hazard ratio for CVD events was 1.19 (95% confidence interval [CI], 1.06-1.34) in patients with cardio-renal disease and 2.31 (95% CI, 1.95-2.74) in patients without cardio-renal disease compared to patients with diabetes without risk factors. In subjects with diabetes and cardio-renal disease, patients with four or five poorly controlled risk factors had a higher risk of CVD mortality compared to subjects without risk factors (hazard ratio, 1.64; 95% CI, 1.18-2.30).Conclusion Controlling cardiovascular risk factors reduced the incidence of CVD events in patients with diabetes, especially those without cardio-renal disease. The degree of risk control was strongly associated with CVD mortality in patients with diabetes with baseline cardio-renal disease.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [1] Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Zinman, Bernard
    Inzucchi, Silvio E.
    Lachin, John M.
    Wanner, Christoph
    Fitchett, David
    Kohler, Sven
    Mattheus, Michaela
    Biomath, Dipl
    Woerle, Hans J.
    Broedl, Uli C.
    Johansen, Odd Erik
    Albers, Gregory W.
    Diener, Hans Christoph
    STROKE, 2017, 48 (05) : 1218 - +
  • [2] Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus
    Brownrigg, Jack R. W.
    de Lusignan, Simon
    McGovern, Andrew
    Hughes, Cian
    Thompson, Matthew M.
    Ray, Kausik K.
    Hinchliffe, Robert J.
    HEART, 2014, 100 (23) : 1837 - +
  • [3] No Increased Risk of Cardiovascular Events with Dapagliflozin in Elderly Patients with Type 2 Diabetes Mellitus, Cardiovascular Disease, and Hypertension
    Gause-Nilsson, Ingrid Ami
    Sonesson, Christian
    Johansson, Peter A.
    Sugg, Jennifer E.
    Johnsson, Eva
    DIABETES, 2015, 64 : A4 - A4
  • [4] No increased risk of cardiovascular events with dapagliflozin in elderly patients with type 2 diabetes mellitus, cardiovascular disease and hypertension
    Gause-Nilsson, I.
    Sonesson, C.
    Johansson, P. A.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S362 - S363
  • [5] Multiple risk factor control and risk of cardiovascular events and mortality in people with type 2 diabetes in the UK
    Wright, Alison K.
    Ortegon, Fabian Suarez
    Walker, Jeremy
    Kontopantelis, Evangelos
    Buchan, Iain
    Emsley, Richard
    Sattar, Naveed
    Ashcroft, Darren M.
    Wild, Sarah
    Rutter, Martin K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 309 - 310
  • [6] Strict control of modifiable cardiovascular risk factors in patients with type 2 diabetes mellitus
    Javier del Canizo Gomez, Francisco
    Moreira Andres, Maria Natividad
    MEDICINA CLINICA, 2008, 130 (17): : 641 - 644
  • [7] An audit of glycaemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus
    P. Downey
    L. O’Shea
    D. Dillon
    M. Corbett
    S. Sreenan
    Irish Journal of Medical Science, 2002, 171 (Suppl 5) : 11 - 12
  • [8] Cardiovascular risk factors in patients with type 2 diabetes mellitus
    Carolina Vintimilla, Evelin
    Vintimilla Molina, Jhojana Rosati
    Carmendel Rocio Parra
    Martinez Santander, Diana Antonieta
    Martinez Santander, Carlos Jose
    del Rocio Andrade, Neida
    Cumbe Guerrero, Karla Maria
    Cardenas Heredia, Fredy Rosendo
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2018, 13 (04): : 356 - 360
  • [9] Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
    Tsujimoto, Tetsuro
    Sugiyama, Takehiro
    Shapiro, Martin F.
    Noda, Mitsuhiko
    Kajio, Hiroshi
    HYPERTENSION, 2017, 70 (01) : 103 - 110
  • [10] Reducing cardiovascular risk in patients with type 2 diabetes mellitus
    Nicholls, Stephen J.
    Ryden, Lars
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2010, 17 : S1 - S1